Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Mol Biosyst. 2005 May;1(1):17-26.

Genomics and the second golden era of cancer drug development.

Author information

  • Cancer Research UK Centre for Cancer Therapeutics, Sutton, UK. paul.workman@icr.ac.uk

Abstract

The first golden era of cancer drug development was initiated in the 1940s and gave rise to the cytotoxic agents that dominate current cancer medicine. The second golden era is now underway in which cancer genomics will direct drug development.

PMID:
16948194
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk